These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 711926)

  • 1. Comparative metabolism of chloral hydrate and triclofos.
    Sellers EM; Lang-Sellers M; Koch-Weser J
    J Clin Pharmacol; 1978 Oct; 18(10):457-61. PubMed ID: 711926
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism of trichloroethylene in man. II. Pharmacokinetics of metabolites.
    Müller G; Spassovski M; Henschler D
    Arch Toxicol; 1974; 32(4):283-95. PubMed ID: 4480028
    [No Abstract]   [Full Text] [Related]  

  • 3. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement of chloral hydrate, trichloroethanol, trichloroacetic acid and monochloroacetic acid in the serum and the urine by gas chromatography.
    Ogata M; Saeki T
    Int Arch Arbeitsmed; 1974 Mar; 33(1):49-58. PubMed ID: 4831416
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacokinetic analysis of chloral hydrate and its metabolism in B6C3F1 mice.
    Abbas RR; Seckel CS; Kidney JK; Fisher JW
    Drug Metab Dispos; 1996 Dec; 24(12):1340-6. PubMed ID: 8971140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chloral hydrate sedation in neonates and infants--clinical and pharmacologic considerations.
    Reimche LD; Sankaran K; Hindmarsh KW; Kasian GF; Gorecki DK; Tan L
    Dev Pharmacol Ther; 1989; 12(2):57-64. PubMed ID: 2714158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of chloral hydrate to trichloroethanol in brain extracts.
    Tabakoff B; Vugrincic C; Anderson R; Alivisatos SG
    Biochem Pharmacol; 1974 Jan; 23(2):455-60. PubMed ID: 4149795
    [No Abstract]   [Full Text] [Related]  

  • 8. Potentiation of warfarin-induced hypoprothrombinemia by chloral hydrate.
    Sellers EM; Koch-Weser J
    N Engl J Med; 1970 Oct; 283(16):827-31. PubMed ID: 5458032
    [No Abstract]   [Full Text] [Related]  

  • 9. Interaction of chloral hydrate and ethanol in man. I. Metabolism.
    Sellers EM; Lang M; Koch-Weser J; LeBlanc E; Kalant H
    Clin Pharmacol Ther; 1972; 13(1):37-49. PubMed ID: 4550322
    [No Abstract]   [Full Text] [Related]  

  • 10. The salivary secretion and clearance in the horse of chloral hydrate and its metabolites.
    Alexander F; Horner MW; Moss MS
    Biochem Pharmacol; 1967 Jul; 16(7):1305-11. PubMed ID: 6053598
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of chloral hydrate and its metabolites, trichloroethanol and trichloroacetic acid, on bilirubin-albumin binding.
    Onks DL; Robertson AF; Brodersen R
    Pharmacol Toxicol; 1992 Sep; 71(3 Pt 1):196-7. PubMed ID: 1438041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicokinetics of chloral hydrate in ad libitum-fed, dietary-controlled, and calorically restricted male B6C3F1 mice following short-term exposure.
    Seng JE; Agrawal N; Horsley ET; Leakey TI; Scherer EM; Xia S; Allaben WT; Leakey JE
    Toxicol Appl Pharmacol; 2003 Dec; 193(2):281-92. PubMed ID: 14644628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A species comparison of chloral hydrate metabolism in blood and liver.
    Lipscomb JC; Mahle DA; Brashear WT; Garrett CM
    Biochem Biophys Res Commun; 1996 Oct; 227(2):340-50. PubMed ID: 8878519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevation of blood urea nitrogen from the administration of chloral hypnotics.
    WIEG H
    Am J Med Technol; 1960; 26():111-4. PubMed ID: 13844596
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical pharmacokinetics of hypnotics.
    Breimer DD
    Clin Pharmacokinet; 1977; 2(2):93-109. PubMed ID: 16715
    [No Abstract]   [Full Text] [Related]  

  • 16. Enhancement of warfarin-induced hypoprothrombinemia by triclofos.
    Sellers EM; Lang M; Koch-Weser J; Colman RW
    Clin Pharmacol Ther; 1972; 13(6):911-5. PubMed ID: 5081604
    [No Abstract]   [Full Text] [Related]  

  • 17. Positive interference.
    Harrison SP
    Ann Clin Biochem; 1992 Sep; 29 ( Pt 5)():570-1. PubMed ID: 1444174
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolism of chloral hydrate in mice and rats after single and multiple doses.
    Beland FA; Schmitt TC; Fullerton NF; Young JF
    J Toxicol Environ Health A; 1998 Jun; 54(3):209-26. PubMed ID: 9643873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. THE USE OF TRICLOFOS DURING LABOUR.
    RUSHTON RJ
    Practitioner; 1964 Jan; 192():126-7. PubMed ID: 14106642
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of monosodium trichlorethyl phosphate (triclofos) as a preoperative sedative compared to chloral hydrate and a placebo.
    Henschel EO; Grosshandler SL; Tavera MV; Powondra PF; Listwan W
    Curr Ther Res Clin Exp; 1967 Sep; 9(9):453-6. PubMed ID: 4963977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.